AVITA Medical (RCEL) Net Cash Flow (QoQ) (2019 - 2025)
AVITA Medical (RCEL) Net Cash Flow (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn |
| 10 | AVITA Medical | 134.29 Mn | 117.95 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -261.54% |
| Sep 30, 2025 | 220.80% |
| Jun 30, 2025 | -423.66% |
| Mar 31, 2025 | 117.87% |
| Dec 31, 2024 | -486.60% |
| Sep 30, 2024 | 136.93% |
| Jun 30, 2024 | 109.70% |
| Mar 31, 2024 | 82.02% |
| Dec 31, 2023 | -314.65% |
| Sep 30, 2023 | 41.92% |
| Jun 30, 2023 | -4.57% |
| Mar 31, 2023 | 1,728.50% |
| Jun 30, 2022 | -100.24% |
| Sep 30, 2021 | 102.89% |
| Jun 30, 2021 | -147.02% |
| Mar 31, 2021 | 1,015.85% |
| Dec 31, 2020 | 24.88% |
| Mar 31, 2020 | -110.58% |
| Dec 31, 2019 | 1,527.92% |